What this means
Mice given a treatment aimed at a virus-like gene showed less weight gain and better blood sugar control. This study was in mice and cells, so it does not show the same would happen in people.
Plain-English summary written by an AI model from the abstract. The original is below.
- Who it was tested in
- Mice on a high-fat diet, plus mouse and human cells in a lab
- Kind of research
- A study
The science
- Original title
- Immunotherapy targeting an endogenous retrovirus decreases islet senescence markers and preserves glucose control in a mouse model of type 2 diabetes.
- Authors
- Andersen DB, Skeltved N, González GM et al.
- Journal
- Molecular metabolism
- Published
- Oct 29, 2026
- Study type
- Study
- PMID
- 42956890 ↗
Abstract
Type-2-diabetes is characterized by progressive metabolic stress and accumulation of senescent cells in key metabolic tissues, such as the pancreas, adipose tissue, and liver. Cellular senescence - an irreversible growth-arrested, and pro-inflammatory cell state can lead to induction of endogenous retrovirus (ERV) expression, which can also trigger cellular senescence. This possibly implies that a self-reinforcing ERV-senescence axis contributes to the metabolic decline and T2D. Here we developed and tested a mouse endogenous retrovirus (muERV) based active immunotherapy targeted at the most intact muERV, IAPE (Intracisternal A-type Particles elements with an Envelope) to eliminate cells expressing muERVs and senescence associated proteins in a mouse model of accelerated diabetes combining a high-fat diet (HFD) with dexamethasone (DEX) and streptozotocin (STZ) (DS-HFD). Immunized DS-HFD mice (DS-HFD + IAPE-Tx) showed increased B and T cell responses towards IAPE. Antisera generated using our IAPE-targeted active immunotherapy was used to confirm activation of IAPE expression in the murine β-cell line MIN-6, following both inflammatory (cytokines) and chemical stress (STZ and DEX). In Vivo, DS-HFD + IAPE-Tx mice showed reduced weight gain, improved fasting insulin-glucose homeostasis and oral glucose tolerance. They furthermore showed reduction in histomorphometry features consistent with steatosis, hepatocyte binucleation, reduced adipocyte size, and pancreatic islet senescence markers p16INK4a and p21Cip1/waf1, with a slight decrease in islet IAPE. Finally, we show activation of a human orthologue to IAPE, HERV-K, in cytokine-exposed isolated human pancreatic islets and EndoC-βH5 β-cells. Together, our results suggest that ERV antigens are expressed in metabolic disease models and may be targeted by immunotherapy to improve metabolic parameters, through a potential senolytic or senostatic-related but so far undefined mechanism.
Andersen DB, Skeltved N, González GM et al. Immunotherapy targeting an endogenous retrovirus decreases islet senescence markers and preserves glucose control in a mouse model of type 2 diabetes. Molecular metabolism. 2026. doi:10.1016/j.molmet.2026.102466. PMID: 42956890. https://pubmed.ncbi.nlm.nih.gov/42956890/
Related research
New fluorescent sensor detects cells aging from cancer and lung drugs
Researchers built a glowing probe that lights up only in certain aged cells. It may help scientists track these cells in living animals, but this is early lab work.
Mixing a senescence-clearing drug with trametinib slowed glioma regrowth in mice
Researchers found a drug combination that cleared aging-like tumour cells in mice and slowed regrowth. This does not show the combination would work the same way in children.
Aging cells that support stem cells may disrupt them through chemical signals
This is a review that pulls together older and newer studies. It proposes a model, but it does not show that the model is true.
Cx43 protein may boost breast cancer drug response in lab tests
Researchers studied a protein called Cx43 that helps cells talk to each other. They found it may help a breast cancer drug slow tumor growth. This early work is not yet checked by other scientists, so it does not show this would help people.
A new vaccine clears aging cells in mice and may extend lifespan
Researchers made a vaccine aimed at old, worn-out cells called senescent cells. In mice, it cleared some of these cells and helped metabolism. This is early work, so it does not show the vaccine would help people.
Review of how the FOXO4 protein may guard cells against damage and aging
This review sorted past studies on FOXO4 by how directly they tested it. Some links are well supported, but many antioxidant effects are still based on related proteins.
See all research on Senolytics →